סינוקליר טבליות ישראל - עברית - Ministry of Health

סינוקליר טבליות

dr.samuelov importing & marketing ltd, israel - common sorrel herb; elder flower; gentian root; primula flower with calyx; verbena herb - טבליות מצופות - common sorrel herb 36 mg; gentian root 12 mg; primula flower with calyx 36 mg; elder flower 36 mg; verbena herb 36 mg

סינוקליר סירופ ישראל - עברית - Ministry of Health

סינוקליר סירופ

dr.samuelov importing & marketing ltd - extract (1:38.5) from 0.011 g of a mixture of gentian root, verbena herb, common sorrel herb, elder flower, primula flower with calyx (1:3:3:3:3);1. extracting agent: ethanol 59 % (v/v), 2. - 4. extracting agent: purified water - סירופ - extract (1:38.5) from 0.011 g of a mixture of gentian root, verbena herb, common sorrel herb, elder flower, primula flower with calyx (1:3:3:3:3);1. extracting agent: ethanol 59 % (v/v), 2. - 4. extracting agent: purified water 417 mg/ml

primary antibodies-benchmark xt ישראל - עברית - Ministry of Health

primary antibodies-benchmark xt

גאמידור דיאגנוסטיקה בע"מ - מומחה - מכשיר וראגנטים לצביעות אימונוהסטוכמיה ואינסיטוהיברידיזציה

בטאדין תרסיס לשימוש חיצוני ישראל - עברית - Ministry of Health

בטאדין תרסיס לשימוש חיצוני

rafa laboratories ltd - povidone-iodine - povidone-iodine 2.5 % - povidone-iodine

אבילק סירופ ישראל - עברית - Ministry of Health

אבילק סירופ

padagis israel pharmaceuticals ltd, israel - lactulose - סירופ - lactulose 66.7 g / 100 ml - lactulose - lactulose - constipation. acute and chronic hepatic encephalopathy.

טרקליר 62.5 מג ישראל - עברית - Ministry of Health

טרקליר 62.5 מג

j-c health care ltd - bosentan - טבליות מצופות פילם - bosentan 62.5 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease

טרקליר 125 מג ישראל - עברית - Ministry of Health

טרקליר 125 מג

j-c health care ltd - bosentan - טבליות מצופות פילם - bosentan 125 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease

טריטייס  קומפ 2.5 מג  12.5 מג ישראל - עברית - Ministry of Health

טריטייס קומפ 2.5 מג 12.5 מג

sanofi israel ltd - hydrochlorothiazide; ramipril - טבליה - ramipril 2.5 mg; hydrochlorothiazide 12.5 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

טריטייס קומפ 5 מג  25 מג ישראל - עברית - Ministry of Health

טריטייס קומפ 5 מג 25 מג

sanofi israel ltd - hydrochlorothiazide; ramipril - טבליה - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

צפוניציד טבע ישראל - עברית - Ministry of Health

צפוניציד טבע

salomon,levin & elstein ltd - cefonicide as sodium - אבקה להכנת תמיסה לזריקה - cefonicide as sodium 1000 mg/vial - cefonicide - cefonicide - treatment of serious bacterial infections caused by microorganisms susceptible to cefonicid. studies on specimens obtained prior to therapy should be used to determine the susceptibility or the causative organisms to cefonicid.therapy with cefonicid may be initiated pending results of the studies however.treatment should be adjusted according to study findings. cefonicid-teva is indicated in the treatment of the infections of the lower respiratory tract urinary tract skin and skin structure bone and joints. in the treatment of the above-mentioned infections the product is particularly used in weak and/or immuno-depressed patients. surgical prophylaxis: the administration of a single 1 g. dose of cefonicid-teva before surgery may reduce the incidence of post-operative infections caused by susceptible microorganisms in patients undergoing surgical procedures classified as contaminated or potentially contaminated or in patients in whom infection at the operative site would present a serious risk providing protec